Residential Treatment Center Level 3.1 denials in California external review
In the California DMHC record, independent physician reviewers decided 14 published external-review cases involving Residential Treatment Center Level 3.1and overturned the plan’s denial in 85.7%. That is a historical result among cases that reached this program, not a forecast for an individual appeal.
Conditions behind Residential Treatment Center Level 3.1 denials
| Category | Decisions | Overturned |
|---|---|---|
| Opioid Use Disorder | 7 | 100% |
| Depression | 4 | 100% |
| Alcohol Use Disorder | 4 | 100% |
| Substance Use Disorder | 3 | 33.3% |
| Post-traumatic Stress Disorder | 3 | 100% |
What the reviewers wrote
Where the denial was overturned
Nature of Statutory Criteria/Case Summary: The patient has requested reimbursement for residential treatment center (RTC) (ASAM 3.1) level of care. Findings: The physician reviewer found that Per the American Society of Addiction Medicine (ASAM) criteria, this patient meets Level 3.1 criteria for RTC services for the time period under review. For Dimension 1, the patient’s intoxication and associated risk, withdrawal and associated risks, and addiction medication needs should be discussed and scored. The medical records indicated that the patient had moderate-severe symptoms of withdrawal from both opiates and benzodiazepines. The patient’s universal urine toxicology on admission was positive for fentanyl, methamphetamine, and benzodiazepines.
Nature of Statutory Criteria/Case Summary: The patient has requested reimbursement and prospective authorization and coverage for all or any of the residential treatment center (RTC) services, specifically ASAM level 3.1. Per American Society of Addiction Medicine (ASAM) criteria, this patient met Level 3.1 criteria for RTC services. ASAM criteria focuses on six dimensions to determine the appropriate level of care, which includes: (1) intoxication and withdrawal potential; (2) biomedical conditions; (3) emotional, behavioral and cognitive conditions; (4) readiness to change; (5) relapse, continued use, or continued problem potential; and (6) recovery environment. For dimension 1, the patient has a history of seizures during opiate withdrawal in the past. She does not have acute symptoms of withdrawal. The patient’s withdrawal needs were safely managed in a Level 3.1 setting.
Where the denial was upheld
Findings: The physician reviewer found that Nature of Statutory Criteria/Case Summary: The patient has requested reimbursement for residential treatment center (RTC) services, specifically ASAM level 3.1. ASAM criteria focus on six dimensions to determine the appropriate level of care, which includes: (1)intoxication and withdrawal potential; (2)biomedical conditions; (3)emotional, behavioral, and cognitive conditions; (4)readiness to change; (5)relapse, continued use, or continued problem potential; and (6)recovery environment. According to the ASAM criteria, the patient does not meet level 3.1 criteria for RTC services.For dimension 1, the patient did not have any symptoms of acute withdrawal after completing detoxification services and was being treated in level 3.1 RTC.
Nature of Statutory Criteria/Case Summary: A patient has requested reimbursement and prospective authorization and coverage for residential treatment center (RTC) (ASAM 3.1) level of care. Per the American Society of Addiction Medicine (ASAM) criteria, this patient does not meet Level 3.1 criteria for RTC services for the time period under review. ASAM criteria focuses on six dimensions to determine the appropriate level of care, which includes: (1) intoxication and associated risk, withdrawal and associated risks, and addiction medication needs; (2) biomedical conditions including physical health concerns and pregnancy-related concerns; (3) psychiatric and cognitive conditions and history including active psychiatric symptoms and persistent disability; (4) substance use-related risks including the likelihood of engaging in risky substance use and the likelihood of engaging in risky subs…
Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California external-review outcomes. Other state and federal programs have different eligibility rules, processes, and current availability; the rates here do not transfer to those programs or predict an individual result. Excerpts are quoted verbatim from the public record and describe this treatment generally, not any individual case.
These outcomes describe eligible cases completed through California DMHC’s Independent Medical Review program. They do not estimate the chance that an internal appeal, an external review in another jurisdiction, or your individual case will succeed. Use the record to identify evidence patterns involving Residential Treatment Center Level 3.1, then check the rights and deadlines that apply to your plan.
SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · AGGREGATES + DEIDENTIFIED DECISION EXCERPTS/REFERENCE IDS · METHODOLOGY